Ace level
Pro Research Analysisby 
Searched over 200M research papers for "ace level"
Consensus Meter
Genetic Control of Plasma ACE Levels: Insights from Recent Research
Introduction to ACE Gene Polymorphism and Plasma Levels
The angiotensin I-converting enzyme (ACE) plays a crucial role in the renin-angiotensin system, which regulates blood pressure and fluid balance. Variations in plasma ACE levels have been linked to genetic factors, particularly the insertion/deletion (I/D) polymorphism of the ACE gene. This article synthesizes recent research findings on the genetic control of plasma ACE levels, focusing on the role of ACE gene polymorphisms.
ACE Gene Polymorphism and Plasma ACE Levels
Insertion/Deletion (I/D) Polymorphism
The I/D polymorphism in the ACE gene is a significant determinant of plasma ACE levels. Studies have shown that this polymorphism accounts for a substantial portion of the variance in ACE levels among individuals. For instance, one study involving 80 healthy subjects found that the I/D polymorphism explained 47% of the total phenotypic variance in serum ACE levels. Another study confirmed that the I/D polymorphism contributes significantly to the variability of ACE levels, although it does not fully account for the genetic regulation observed in segregation analyses.
Familial Correlations and Major Gene Effects
Research involving nuclear families has demonstrated that the familial resemblance in ACE levels can be attributed to the transmission of a codominant major gene. This major gene effect is strongly linked to the I/D polymorphism, suggesting that a variant of the ACE gene in linkage disequilibrium with the I/D polymorphism controls plasma ACE levels. The marker allele I is consistently associated with lower ACE levels, indicating a significant genetic influence on ACE activity.
Discovery of New Polymorphisms
Further investigations have identified additional polymorphisms within the ACE gene that may influence plasma ACE levels. A study comparing ACE gene sequences in individuals with contrasting ACE levels and I/D genotypes discovered ten new polymorphisms. These polymorphisms were categorized into two groups based on their location in the gene, and both groups showed significant associations with ACE levels after adjusting for the I/D polymorphism. This suggests the presence of multiple quantitative trait loci (QTLs) within the ACE gene that act additively to regulate ACE levels.
Clinical Implications of ACE Levels
ACE Levels and Disease Prognosis
Elevated ACE levels have been associated with various clinical conditions. For example, higher ACE levels are linked to worse outcomes in COVID-19 patients, including increased ICU admissions and mortality rates. This highlights the potential of ACE levels as a prognostic marker in severe infections and other diseases.
ACE Levels in Sarcoidosis
In patients with sarcoidosis, elevated serum ACE levels are a marker of active disease. Studies have shown that ACE levels are significantly higher in patients with active sarcoidosis compared to those with resolved disease or other chronic lung conditions. This makes serum ACE a valuable tool for diagnosing and monitoring sarcoidosis.
Conclusion
The genetic control of plasma ACE levels is complex and involves multiple polymorphisms within the ACE gene. The I/D polymorphism plays a significant role, but additional variants also contribute to the regulation of ACE activity. Understanding these genetic factors is crucial for developing targeted therapies and improving prognostic assessments in diseases associated with altered ACE levels. Further research is needed to fully characterize the functional variants and their clinical implications.
Sources and full results
Most relevant research papers on this topic